Xencor (XNCR) Assets Average (2014 - 2026)
Xencor's (XNCR) quarterly Assets Average came in at $806.2 million in Q1 2026, down 13.16% year-on-year from $928.3 million in Q1 2025, and down 7.57% on a QoQ basis from $872.2 million in Q4 2025.
Xencor (XNCR) Assets Average (2014 - 2026) Analysis & Trends
Xencor (XNCR) has 13 years of Assets Average data on file, last reported at $806.2 million in Q1 2026.
- On a quarterly basis, Assets Average fell 13.16% year-over-year to $806.2 million in Q1 2026; TTM through Mar 2026 was $806.2 million, a 13.16% decrease from a year earlier, with the FY2025 full-year figure at $913.7 million, down 4.68% from the prior year.
- Assets Average for Q1 2026 stood at $806.2 million, down from $872.2 million in the prior quarter.
- Over the last five years, Assets Average for XNCR reached as high as $975.9 million in Q4 2024 and fell as low as $778.3 million in Q3 2023.
- Historically, Assets Average has averaged $865.9 million across 5 years, with a median of $868.7 million in 2024.
- Across the five-year window, Assets Average increased 23.11% in 2022 and fell 13.16% in 2026, its largest moves.
- Year by year, Assets Average stood at $840.8 million in 2022, then gained by 3.69% to $871.8 million in 2023, then climbed by 11.95% to $975.9 million in 2024, then fell by 10.63% to $872.2 million in 2025, then retreated by 7.57% to $806.2 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $806.2 million in Q1 2026, $872.2 million in Q4 2025, and $874.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 806.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 806.17 Mn |
| Dec 31, 2025 | 872.15 Mn |
| Sep 30, 2025 | 874.12 Mn |
| Jun 30, 2025 | 892.06 Mn |
| Mar 31, 2025 | 928.32 Mn |
| Dec 31, 2024 | 975.92 Mn |
| Sep 30, 2024 | 920.26 Mn |
| Jun 30, 2024 | 868.73 Mn |
| Mar 31, 2024 | 930.99 Mn |
| Dec 31, 2023 | 871.78 Mn |
| Sep 30, 2023 | 778.28 Mn |
| Jun 30, 2023 | 790.77 Mn |
| Mar 31, 2023 | 824.84 Mn |
| Dec 31, 2022 | 840.77 Mn |
| Sep 30, 2022 | 843.30 Mn |
| Jun 30, 2022 | 854.62 Mn |
| Mar 31, 2022 | 848.07 Mn |
| Dec 31, 2021 | 767.74 Mn |
| Sep 30, 2021 | 696.43 Mn |
| Jun 30, 2021 | 694.17 Mn |